JP2024523466A - IFN-γシグナル伝達経路の調節のためのオリゴヌクレオチド - Google Patents
IFN-γシグナル伝達経路の調節のためのオリゴヌクレオチド Download PDFInfo
- Publication number
- JP2024523466A JP2024523466A JP2023578896A JP2023578896A JP2024523466A JP 2024523466 A JP2024523466 A JP 2024523466A JP 2023578896 A JP2023578896 A JP 2023578896A JP 2023578896 A JP2023578896 A JP 2023578896A JP 2024523466 A JP2024523466 A JP 2024523466A
- Authority
- JP
- Japan
- Prior art keywords
- nucleotides
- antisense strand
- dsrna
- strand
- sense strand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3515—Lipophilic moiety, e.g. cholesterol
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163213506P | 2021-06-22 | 2021-06-22 | |
| US63/213,506 | 2021-06-22 | ||
| US202263331563P | 2022-04-15 | 2022-04-15 | |
| US63/331,563 | 2022-04-15 | ||
| PCT/US2022/034297 WO2022271666A1 (en) | 2021-06-22 | 2022-06-21 | OLIGONUCLEOTIDES FOR IFN-γ SIGNALING PATHWAY MODULATION |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523466A true JP2024523466A (ja) | 2024-06-28 |
| JP2024523466A5 JP2024523466A5 (cg-RX-API-DMAC7.html) | 2025-07-01 |
Family
ID=84544753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023578896A Pending JP2024523466A (ja) | 2021-06-22 | 2022-06-21 | IFN-γシグナル伝達経路の調節のためのオリゴヌクレオチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240287514A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4359537A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024523466A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240040724A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022298641A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223577A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022271666A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112021002440A2 (pt) | 2018-08-10 | 2021-05-04 | University Of Massachusetts | oligonucleotídeos modificados visando snps |
| CA3174079A1 (en) | 2020-05-26 | 2021-12-02 | Anastasia Khvorova | Synthetic oligonucleotides having regions of block and cluster modifications |
| AU2024231771A1 (en) * | 2023-03-03 | 2025-08-28 | Royal Institution For The Advancement Of Learning/Mcgill University | Dendritic conjugates for the skin delivery of therapeutic oligonucleotides |
| KR20260026070A (ko) * | 2023-06-16 | 2026-02-25 | 에프. 호프만-라 로슈 아게 | Jak1 발현 조절을 위한 이중 가닥 올리고뉴클레오티드 |
| WO2026131801A1 (en) * | 2024-12-17 | 2026-06-25 | F. Hoffmann-La Roche Ag | Double stranded oligonucleotide for modulating jak1 expression |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012156927A1 (en) * | 2011-05-16 | 2012-11-22 | Council Of Scientific & Industrial Research | Method to modulate pigmentation process in the melanocytes of skin |
| WO2020190768A1 (en) * | 2019-03-15 | 2020-09-24 | University Of Massachusetts | Oligonucleotides for tissue specific apoe modulation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998002558A2 (en) * | 1996-07-17 | 1998-01-22 | University Of Medicine And Dentistry Of New Jersey | Chimeric receptors for jak-stat signal transduction |
| US6566132B1 (en) * | 2001-04-26 | 2003-05-20 | Isis Pharmaceuticals, Inc. | Antisense modulation of Interferon gamma receptor 1 expression |
| AU2003209340A1 (en) * | 2002-01-18 | 2003-09-02 | Bristol-Myers Squibb Company | Predictor sets for tyrosine kinase pathways |
| EP2305813A3 (en) * | 2002-11-14 | 2012-03-28 | Dharmacon, Inc. | Fuctional and hyperfunctional sirna |
| US20070087344A1 (en) * | 2003-04-23 | 2007-04-19 | Bioseek, Inc. | Methods for characterizing signaling pathways and compounds that interact therewith |
| WO2006094293A2 (en) * | 2005-03-03 | 2006-09-08 | President And Fellows Of Harvard College | Slim compositions and methods of use thereof |
| US20100247580A1 (en) * | 2007-11-30 | 2010-09-30 | Thierry Coche | Method for Classifying Cancer Patients as Responder or Non-Responder to Immunotherapy |
| JP2014501097A (ja) * | 2009-07-06 | 2014-01-20 | アルナイラム ファーマシューティカルズ, インコーポレイテッド | 生物由来物質の産生を高めるための組成物及び方法 |
| CN107012149A (zh) * | 2010-11-19 | 2017-08-04 | 艾德拉药物股份有限公司 | 调控基于toll‑样受体的免疫应答的免疫调节寡核苷酸(iro)化合物 |
| CN104540946A (zh) * | 2012-05-16 | 2015-04-22 | Rana医疗有限公司 | 用于调节utrn表达的组合物和方法 |
| FR3098712A1 (fr) * | 2019-07-15 | 2021-01-22 | Commissariat à l'énergie atomique et aux énergies alternatives | Séquences siARN ciblant l'expression des gènes JAK1 ou JAK3 humains pour une utilisation thérapeutique |
-
2022
- 2022-06-21 WO PCT/US2022/034297 patent/WO2022271666A1/en not_active Ceased
- 2022-06-21 KR KR1020247000555A patent/KR20240040724A/ko active Pending
- 2022-06-21 EP EP22829131.6A patent/EP4359537A4/en active Pending
- 2022-06-21 JP JP2023578896A patent/JP2024523466A/ja active Pending
- 2022-06-21 CA CA3223577A patent/CA3223577A1/en active Pending
- 2022-06-21 AU AU2022298641A patent/AU2022298641A1/en active Pending
-
2023
- 2023-12-21 US US18/393,044 patent/US20240287514A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012156927A1 (en) * | 2011-05-16 | 2012-11-22 | Council Of Scientific & Industrial Research | Method to modulate pigmentation process in the melanocytes of skin |
| WO2020190768A1 (en) * | 2019-03-15 | 2020-09-24 | University Of Massachusetts | Oligonucleotides for tissue specific apoe modulation |
Non-Patent Citations (1)
| Title |
|---|
| PLOS ONE, vol. 14, JPN6026017878, 2019, pages 0222437 - 1, ISSN: 0005856270 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20240287514A1 (en) | 2024-08-29 |
| KR20240040724A (ko) | 2024-03-28 |
| CA3223577A1 (en) | 2022-12-29 |
| WO2022271666A1 (en) | 2022-12-29 |
| EP4359537A4 (en) | 2026-05-06 |
| EP4359537A1 (en) | 2024-05-01 |
| AU2022298641A1 (en) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230416735A1 (en) | Oligonucleotides for atn1 modulation | |
| JP2023550485A (ja) | Dgat2調節のためのオリゴヌクレオチド | |
| KR20230004448A (ko) | Mapt 조절을 위한 올리고뉴클레오티드 | |
| JP2023522701A (ja) | Msh3調節のためのオリゴヌクレオチド | |
| US20220090069A1 (en) | Oligonucleotides for htt-1a modulation | |
| WO2021243291A2 (en) | Oligonucleotides for sars-cov-2 modulation | |
| US20240287514A1 (en) | Oligonucleotides for ifn-gamma signaling pathway modulation | |
| WO2023081908A2 (en) | Oligonucleotides for sod1 modulation | |
| US20230392146A1 (en) | Oligonucleotides for app modulation | |
| WO2023133550A2 (en) | Oligonucleotides for mecp2 modulation | |
| WO2023114989A2 (en) | Oligonucleotides for mlh3 modulation | |
| WO2023114959A2 (en) | Oligonucleotides for mlh1 modulation | |
| US20220348918A1 (en) | Oligonucleotides for syngr-3 modulation | |
| KR20230002327A (ko) | Snca 조절을 위한 올리고뉴클레오티드 | |
| WO2023014654A2 (en) | Oligonucleotides for htt-1a modulation | |
| US20240035027A1 (en) | Oligonucleotides for pms2 modulation | |
| US20240052344A1 (en) | Oligonucleotides for pms1 modulation | |
| CN117642508A (zh) | 用于IFN-γ信号传导途径调节的寡核苷酸 | |
| WO2025006682A2 (en) | Sglt-2 targeting oligonucleotides | |
| JP2025532983A (ja) | S6k1を標的とするオリゴヌクレオチド | |
| WO2025006739A1 (en) | Oligonucleotides with internucleotide linkage modifications for kidney targeting |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20240502 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20250206 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250620 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250620 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260512 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260810 |